Home › Prescription medicine › Boothwyn Pharmacy LLC — Semaglutide, 2.5 mg/mL…
Boothwyn Pharmacy LLC — Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
Do not stop taking this without speaking to your pharmacist or doctor.
What’s wrong
Subpotent Drug
The Recall Registry rates this serious — FDA Class II: temporary or medically reversible health harm.
What to do
Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.
Who to contact: Recalling firm: Boothwyn Pharmacy LLC
The product
Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
Details
- Units affected
- 642 vials
- Recall date
- July 9, 2025
- Brand
- Boothwyn Pharmacy LLC
U.S. Nationwide
The official notice
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “Boothwyn Pharmacy LLC — Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine